GlassScriptPhysician profile
Wonsuk Joo
NPI 1609224872
$50,481.49
in general payments reported to CMS, 2019-2025
11 companies · $22K in 2025
The $22K reported for 2025 was more than what 99% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $180 · 2020: $2,975 · 2021: $1,136 · 2022: $2,462 · 2023: $10K · 2024: $11K · 2025: $22K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $43K · Food and Beverage: $251.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $43,477.00 |
| Food and Beverage | $250.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hiossen, INC. | $49,677.00 | 2020-2025 | |
| Align Technology, INC. | $225.63 | 2020-2024 | Invisalign, Itero Element 5d Plus |
| Straumann USA LLC | $185.18 | 2019-2021 | |
| Dentsply Sirona INC | $150.95 | 2021-2024 | Primescan Connect |
| Septodont INC. | $72.93 | 2020 | |
| Nobel Biocare USA | $60.00 | 2023 | Nobelactive |
| Neoss, INC. | $43.44 | 2024 | Neoss Implant System |
| Gc America INC. | $20.42 | 2019 | |
| 3m Company | $18.50 | 2021 | |
| Kerr Corporation | $14.51 | 2021 | |
| Zimmer Biomet Holdings, INC. | $12.93 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wonsuk Joo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.